These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Protection of mice from H5N1 influenza challenge by prophylactic DNA vaccination using particle mediated epidermal delivery. Sharpe M; Lynch D; Topham S; Major D; Wood J; Loudon P Vaccine; 2007 Aug; 25(34):6392-8. PubMed ID: 17640779 [TBL] [Abstract][Full Text] [Related]
27. Immune responses and protection efficacy of a recombinant swinepox virus expressing HA1 against swine H3N2 influenza virus in mice and pigs. Xu J; Huang D; Liu S; Lin H; Zhu H; Liu B; Lu C Virus Res; 2012 Aug; 167(2):188-95. PubMed ID: 22584406 [TBL] [Abstract][Full Text] [Related]
28. Pre-vaccination immunity and immune responses to a cell culture-derived whole-virus H1N1 vaccine are similar to a seasonal influenza vaccine. Ehrlich HJ; Müller M; Kollaritsch H; Pinl F; Schmitt B; Zeitlinger M; Loew-Baselli A; Kreil TR; Kistner O; Portsmouth D; Fritsch S; Maritsch F; Aichinger G; Pavlova BG; Barrett PN Vaccine; 2012 Jun; 30(30):4543-51. PubMed ID: 22475864 [TBL] [Abstract][Full Text] [Related]
29. 1976 and 2009 H1N1 influenza virus vaccines boost anti-hemagglutinin stalk antibodies in humans. Miller MS; Tsibane T; Krammer F; Hai R; Rahmat S; Basler CF; Palese P J Infect Dis; 2013 Jan; 207(1):98-105. PubMed ID: 23087428 [TBL] [Abstract][Full Text] [Related]
30. Immunogenic and protective properties of the first Kazakhstan vaccine against pandemic influenza A (H1N1) pdm09 in ferrets. Tabynov K; Kydyrbayev Z; Sansyzbay A; Khairullin B; Ryskeldinova S; Assanzhanova N; Kozhamkulov Y; Inkarbekov D Virol Sin; 2012 Dec; 27(6):345-52. PubMed ID: 23180289 [TBL] [Abstract][Full Text] [Related]
31. DNA priming prior to inactivated influenza A(H5N1) vaccination expands the antibody epitope repertoire and increases affinity maturation in a boost-interval-dependent manner in adults. Khurana S; Wu J; Dimitrova M; King LR; Manischewitz J; Graham BS; Ledgerwood JE; Golding H J Infect Dis; 2013 Aug; 208(3):413-7. PubMed ID: 23633404 [TBL] [Abstract][Full Text] [Related]
32. Comparison of vaccines for induction of heterosubtypic immunity to influenza A virus: cold-adapted vaccine versus DNA prime-adenovirus boost strategies. Lo CY; Wu Z; Misplon JA; Price GE; Pappas C; Kong WP; Tumpey TM; Epstein SL Vaccine; 2008 Apr; 26(17):2062-72. PubMed ID: 18378366 [TBL] [Abstract][Full Text] [Related]
33. Development and application of reference antisera against 15 hemagglutinin subtypes of influenza virus by DNA vaccination of chickens. Lee CW; Senne DA; Suarez DL Clin Vaccine Immunol; 2006 Mar; 13(3):395-402. PubMed ID: 16522783 [TBL] [Abstract][Full Text] [Related]
34. Complete protection against a H5N2 avian influenza virus by a DNA vaccine expressing a fusion protein of H1N1 HA and M2e. Park KS; Seo YB; Lee JY; Im SJ; Seo SH; Song MS; Choi YK; Sung YC Vaccine; 2011 Jul; 29(33):5481-7. PubMed ID: 21664216 [TBL] [Abstract][Full Text] [Related]
35. Influenza A (H1N1) 2009 two-dose immunization of US children: an observer-blinded, randomized, placebo-controlled trial. Plennevaux E; Blatter M; Cornish MJ; Go K; Kirby D; Wali M; Reeves-Hoché MK; Denis M Vaccine; 2011 Feb; 29(8):1569-75. PubMed ID: 21219979 [TBL] [Abstract][Full Text] [Related]
36. Studies on the usefulness of intranasal inactivated influenza vaccines. Tamura S Vaccine; 2010 Aug; 28(38):6393-7. PubMed ID: 20493820 [TBL] [Abstract][Full Text] [Related]
37. Pandemic and seasonal H1N1 influenza hemagglutinin-specific T cell responses elicited by seasonal influenza vaccination. Subbramanian RA; Basha S; Shata MT; Brady RC; Bernstein DI Vaccine; 2010 Dec; 28(52):8258-67. PubMed ID: 21050903 [TBL] [Abstract][Full Text] [Related]
38. Cross reactivity of serum antibody responses elicited by DNA vaccines expressing HA antigens from H1N1 subtype influenza vaccines in the past 30 years. Almansour I; Chen H; Wang S; Lu S Hum Vaccin Immunother; 2013 Oct; 9(10):2049-59. PubMed ID: 23884239 [TBL] [Abstract][Full Text] [Related]
39. Comparison of neutralizing antibody and cell-mediated immune responses to pandemic H1N1 2009 influenza virus before and after H1N1 2009 influenza vaccination of elderly subjects and healthcare workers. Hsu JP; Phoon MC; Koh GC; Chen MI; Lee VJ; Wu Y; Xie ML; Cheong A; Leo YS; Chow VT Int J Infect Dis; 2012 Aug; 16(8):e621-7. PubMed ID: 22704721 [TBL] [Abstract][Full Text] [Related]
40. Differential activities of alpha/beta IFN subtypes against influenza virus in vivo and enhancement of specific immune responses in DNA vaccinated mice expressing haemagglutinin and nucleoprotein. James CM; Abdad MY; Mansfield JP; Jacobsen HK; Vind AR; Stumbles PA; Bartlett EJ Vaccine; 2007 Feb; 25(10):1856-67. PubMed ID: 17240000 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]